Table 4.

Risk factors for death post–kidney transplant in recipients with polycystic kidney disease

VariableHazard Ratio (95% CI)P Value
Age (per decade)1.80 (1.46 to 2.22)<0.001a
Female sex0.85 (0.60 to 1.21)0.37
Non-White race1.54 (0.73 to 3.27)0.26
BMI (per 1 kg/m2 higher BMI)1.07 (1.04 to 1.11)<0.001a
Dialysis before transplantation1.36 (0.88 to 2.12)0.17
Dialysis duration1.00 (1.00 to 1.01)0.53
Coronary artery disease2.50 (1.69 to 3.71)<0.001a
Congestive heart failure0.92 (0.44 to 1.94)0.83
Polycystic liver disease1.02 (0.66 to 1.56)0.94
Deceased donor1.35 (0.89 to 2.03)0.16
Donor age1.24 (1.09 to 1.41)0.001a
Prior kidney transplantation1.40 (0.78 to 2.48)0.26
Induction treatment
 BasiliximabReference
 Thymoglobulinb0.80 (0.50 to 1.27)0.34
 Alemtuzumab0.86 (0.49 to 1.54)0.62
 Other0.46 (0.22 to 0.96)0.04a
 None0.41 (0.15 to 1.12)0.08
Calcineurin-inhibitor maintenance
 TacrolimusReference
 Cyclosporine0.83 (0.54 to 1.27)0.39
 None1.30 (0.70 to 2.40)0.41
Mycophenolate maintenance0.94 (0.46 to 1.91)0.86
HLA mismatch
 0–2 (reference)Reference
 3–41.23 (0.81 to 1.86)0.34
 5–61.10 (0.69 to 1.76)0.69
Nephrectomy at transplantation0.83 (0.54 to 1.28)0.40
  • BMI, body mass index.

  • a P<0.05.

  • b Rabbit anti-thymocyte globulin.